There Is No Illumination in Speculation

Slides:

Advertisements

Similar presentations

Volume 32, Issue 1, Pages (July 1957)

Advertisements

Volume 32, Issue 1, Pages (July 1957)

Tell-tale Telangiectasias

Chest X-ray Screening Improves Outcome in Lung Cancer

Colloquium on Therapy of Right Heart Failure

Left Bundle Branch Block and Intermittent Type A Preexcitation

Environmental Causes of Cancer of the Lung Other Than Tobacco Smoke

An Unusual Cause of Stridor and Progressive Shortness of Breath

When to Be Rash About a Fever and Headache

Right-Sided Chest Pain with Progressive Dyspnea

Volume 56, Issue 1, Pages (July 1969)

Epidemiology and Treatment of Lung Cancer in Seattle

Bovine Tuberculosis Eradication

Robert Pickering, M.D, Fernando J. Martinez, M.D CHEST

Hyperbaric Oxygenation in Cardiac and Pulmonary Disease

Volume 127, Issue 6, Pages (June 2005)

Air Pollution and Chest Disease

Rheumatic Heart Disease in East Pakistan

Navin K. Jain, MD, Thiam H. Lie, MD, FCCP CHEST

Inflammatory Cytokines in the BAL of Patients With ARDS

Respiratory Retention of One Micron Particles in Man

Fever, Skin Eruption, Low Serum Gammaglobulin in a Child with Leukemia

Effects of Prostaglandin E1 on Oxygen Delivery and Consumption in Patients with the Adult Respiratory Distress Syndrome Henry J. Silverman, M.D., F.C.C.P.

Frank W. Ewald, MD, FCCP, Albert H. Scherff, MD CHEST

Treatment of Malignant Pleural Effusion

The Lung Cancer Stage Page

COUNTERPOINT: Is the Apnea-Hypopnea Index the Best Way to Quantify the Severity of Sleep-Disordered Breathing? No Naresh M. Punjabi, MD, PhD, FCCP CHEST

Millennial Health Care

Has the 6-Min Walk Distance Run Its Course?

Counterpoint: Adherence to Early Goal-Directed Therapy

Airway Stenting for Patients With Benign Airway Disease and the Food and Drug Administration Advisory Lund Mark E. , MD, FCCP, Force Seth , MD, FCCP

Some Historical Notes on Behçet's Disease

Decortication after 35 Years

Sleep Apnea, Hypothyroidism and Pulmonary Edema

Volume 152, Issue 4, Pages (October 2017)

PEEP, Auto-PEEP, and Waterfalls

Sundeep Salvi, MD, DNB, PhD, FCCP, Peter J. Barnes, DM, FCCP CHEST

Counterpoint: Should All ICU Patients Receive Continuous Sedation? No

Volume 104, Issue 1, Pages 1-2 (July 1993)

What Went Right Lewis A. Eisen, MD, FCCP, Richard H. Savel, MD CHEST

Reversal of the Anticoagulant Effects of Warfarin by Vitamin K1

Duration of Glucocorticoid Treatment and Outcome in Sepsis

Imaging for the Management of Community-Acquired Pneumonia

Spread the Word About CHEST in 2015

Volume 97, Issue 1, Pages (January 1990)

Brahms' Lullaby Revisited

Volume 149, Issue 6, Pages (June 2016)

Chemical Pneumonitis Due to Exposure to Bromine Compounds

Evolution in Reimbursement for Sleep Studies and Sleep Centers

Giants in Chest Medicine: Professor Atul C. Mehta, MBBS, FCCP

Bedside Calibration Of Pulmonary Artery Catheters

Invasive Pulmonary Aspergillosis

Pulmonary Manifestations in a Case of Multiple Myeloma

Effects of Beta-Adrenergic Agents on Hypokalemia

A Man in His 70s Presenting With Chest Pain and Hematuria

A Single Nasal Prong for Continuous Oxygen Therapy

Myocardial Sarcoidosis Unresponsive to Steroids

Cardiogenic Shock due to Right Ventricular Infarction

Spherical Pneumonia CHEST

Volume 42, Issue 2, Pages (August 1962)

Counterpoint: Should Paralytic Agents Be Routinely Used in Severe ARDS

Calcification of the Coronary Artery

Jason Chertoff, MD, MPH, Paul Stevenson, MD, Hassan Alnuaimat, MD

Digitalis and Angina Pectoris

POINT: Should Inhaled Antibiotic Therapy Be Used Routinely for the Treatment of Bacterial Lower Respiratory Tract Infections in the ICU Setting? Yes

Rebuttal From Drs Mohr and Doerschug

New Members of the Editorial Board

Rebuttal From Dr Kollef

Post-pneumonectomy Pericardial Effusion

Tetracycline Pleurodesis-Associated Acute Renal Failure

Presentation transcript:

There Is No Illumination in Speculation Meduri Gianfranco Umberto , MD, FCCP CHEST Volume 132, Issue 3, Pages 1097-1100 (September 2007) DOI: 10.1378/chest.07-1337 Copyright © 2007 The American College of Chest Physicians Terms and Conditions

Figure 1 Effects on survival of prolonged glucocorticoid treatment initiated before day 14 of ARDS. Mortality was the primary outcome in two of the three trials.45 Mortality is reported as hospital mortality14 or 60-day mortality.5 Figure provided by Professor D. Annane, Universite de Versailes Saint-Quentin en Yvelines, Garches, France. df = degree of freedom. CHEST 2007 132, 1097-1100DOI: (10.1378/chest.07-1337) Copyright © 2007 The American College of Chest Physicians Terms and Conditions